Fulcrum Capital’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.03M | Sell |
40,893
-2,228
| -5% | -$616K | 1.83% | 17 |
|
|
2026
Q1 | $12.7M | Sell |
43,121
-714
| -2% | -$212K | 2.76% | 12 |
|
|
2025
Q4 | $12M | Buy |
43,835
+1,046
| +2% | +$284K | 2.4% | 12 |
|
|
2025
Q3 | $11.6M | Buy |
42,789
+361
| +0.9% | +$98.2K | 2.37% | 13 |
|
|
2025
Q2 | $11.7M | Sell |
42,428
-964
| -2% | -$262K | 2.47% | 13 |
|
|
2025
Q1 | $11.5M | Sell |
43,392
-1,325
| -3% | -$327K | 2.55% | 12 |
|
|
2024
Q4 | $10.4M | Buy |
44,717
+386
| +0.9% | +$88.8K | 2.17% | 15 |
|
|
2024
Q3 | $9.78M | Buy |
44,331
+678
| +2% | +$140K | 2.13% | 14 |
|
|
2024
Q2 | $8.58M | Buy |
43,653
+1,469
| +3% | +$304K | 1.95% | 16 |
|
|
2024
Q1 | $9.08M | Buy |
42,184
+2,910
| +7% | +$611K | 2.16% | 15 |
|
|
2023
Q4 | $8.27M | Sell |
39,274
-1,679
| -4% | -$358K | 2.14% | 18 |
|
|
2023
Q3 | $8.2M | Sell |
40,953
-367
| -0.9% | -$73K | 2.38% | 12 |
|
|
2023
Q2 | $7.66M | Sell |
41,320
-392
| -0.9% | -$72.4K | 2.01% | 18 |
|
|
2023
Q1 | $7.99M | Buy |
41,712
+2,551
| +7% | +$461K | 2.15% | 15 |
|
|
2022
Q4 | $6.59M | Buy |
39,161
+1,810
| +5% | +$315K | 1.9% | 21 |
|
|
2022
Q3 | $6.62M | Sell |
37,351
-610
| -2% | -$121K | 1.97% | 22 |
|
|
2022
Q2 | $7.77M | Buy |
37,961
+9,539
| +34% | +$2.02M | 2.44% | 14 |
|
|
2022
Q1 | $6.76M | Buy |
28,422
+450
| +2% | +$106K | 1.81% | 24 |
|
|
2021
Q4 | $6.39M | Buy |
27,972
+785
| +3% | +$173K | 1.39% | 32 |
|
|
2021
Q3 | $5.26M | Buy |
27,187
+960
| +4% | +$194K | 1.26% | 34 |
|
|
2021
Q2 | $5.58M | Sell |
26,227
-217
| -0.8% | -$45.8K | 1.4% | 32 |
|
|
2021
Q1 | $5.4M | Sell |
26,444
-12,927
| -33% | -$2.55M | 1.55% | 31 |
|
|
2020
Q4 | $7.17M | Buy |
39,371
+2,965
| +8% | +$504K | 2.14% | 19 |
|
|
2020
Q3 | $6.09M | Sell |
36,406
-1,634
| -4% | -$275K | 2.2% | 24 |
|
|
2020
Q2 | $6.18M | Sell |
38,040
-2,041
| -5% | -$366K | 2.34% | 19 |
|
|
2020
Q1 | $6.93M | Sell |
40,081
-391
| -1% | -$77.8K | 3.15% | 7 |
|
|
2019
Q4 | $8.12M | Buy |
40,472
+911
| +2% | +$187K | 2.52% | 11 |
|
|
2019
Q3 | $8.36M | Buy |
39,561
+586
| +2% | +$122K | 2.86% | 7 |
|
|
2019
Q2 | $7.57M | Buy |
38,975
+146
| +0.4% | +$26.9K | 2.77% | 9 |
|
|
2019
Q1 | $6.39M | Buy |
38,829
+2,156
| +6% | +$381K | 2.41% | 15 |
|
|
2018
Q4 | $6.9M | Sell |
36,673
-306
| -0.8% | -$56.5K | 3.11% | 9 |
|
|
2018
Q3 | $6.29M | Sell |
36,979
-106
| -0.3% | -$17.8K | 2.45% | 16 |
|
|
2018
Q2 | $6.08M | Sell |
37,085
-2,927
| -7% | -$478K | 2.9% | 13 |
|
|
2018
Q1 | $6.47M | Sell |
40,012
-484
| -1% | -$77K | 2.11% | 15 |
|
|
2017
Q4 | $5.91M | Buy |
+40,496
| New | +$5.77M | 1.92% | 18 |
|
Other funds holding CME
Fulcrum Capital's CME Position: Q2 2026 in Review
Fulcrum Capital reduced its CME Group (CME) stake by 5.2% in Q2 2026, selling an estimated $616K and leaving 40,893 shares worth $9.03M. The position accounts for 1.83% of the portfolio, ranked #17.
Fulcrum Capital first reported a position in CME in Q4 2017 and has held it in 35 quarters since. The position peaked at $12.7M in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Fulcrum Capital held 40,893 shares of CME Group worth $9.03M as of Q2 2026.
- Fulcrum Capital sold 2,228 CME Group shares in Q2 2026, an estimated $616K.
- CME Group made up 1.83% of Fulcrum Capital's portfolio in Q2 2026, its #17 holding.
- Fulcrum Capital first reported a position in CME Group in Q4 2017 and has held it in 35 quarters since.
- Fulcrum Capital's CME Group position peaked at $12.7M in Q1 2026.
- 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Fulcrum Capital's 13F filing for Q2 2026, filed 21 Jul 2026.